Table 1.

General characteristics of NHBD and HBD transplants performed at the Hospital Clinico San Carlos (Madrid, Spain) from 1989 to 1998a

Characteristic NHBD HBD
Modified Maastricht Donor Category
Type I Type II Type III Type IV Type V P1P2
Donor age (yr) 35.0 ± 1.6 32.7 ± 2.6 21.0 ± 0.4 33.0 ± 5.2 32.3 ± 4.5 0.102 40.5 ± 0.9 0.000
Male recipients (%) 64.0 82.4 50.0 100.0 41.7% 0.095 63.6 0.439
Dialysis time (mo) 40.9 ± 8.2 41.5 ± 8.5 36.5 ± 12.7 9.9 ± 0.9 72.0 ± 18.9 0.264 47.8 ± 2.6 0.471
Recipient age (yr) 47.4 ± 1.9 47.8 ± 2.5 43.6 ± 5.8 50.4 ± 3.1 43.0 ± 3.7 0.327 47.9 ± 0.7 0.792
Male donors (%) 94.0 94.1 100.0 50.0 83.3 0.034 62.1 0.000
HLA match (mean number) 1.86 ± 0.15 2.18 ± 0.20 2.00 ± 0.36 0.50 ± 0.29 1.33 ± 0.28 0.014 2.07 ± 0.06 0.035
Peak PRA (%) 13.2 ± 2.9 16.9 ± 5.5 3.0 ± 1.5 0.7 ± 0.75 32.8 ± 8.9 0.021 15.4 ± 2.4 0.476
Current PRA (%) 3.1 ± 1.4 4.0 ± 2.4 2.0 ± 1.0 0 ± 0 19.6 ± 9.4 0.010 7.4 ± 1.0 0.238
Regraft (%) 10.0 17.6 16.7 0 16.7 0.815 12.7 0.546
Warm ischemia time (min) 100.6 ± 3.9 93.8 ± 6.0 35.0 ± 4.4 50.0 ± 5.8 40.0 ± 9.0 0.000 0 0.000
Cold ischemia time (h) 19.5 ± 0.5 18.7 ± 1.1 21.8 ± 0.9 16.0 ± 1.9 19.2 ± 0.9 0.178 18.3 ± 0.3 0.038
  • a NHBD, non-heart beating donor; HBD, heart beating donor; PRA, panel-reactive antibody; P1, ANOVA of the different NHBD types; P2, t test for independent samples used to compare NHBD and HBD data.